Sumitomo Pharma Co., Ltd. Logo

Sumitomo Pharma Co., Ltd.

R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.

4506 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区道修町2丁目6番8号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sumitomo Pharma Co., Ltd. is a research and development-oriented pharmaceutical company focused on creating innovative medicines and healthcare solutions. The company concentrates its R&D and commercial activities in the therapeutic areas of oncology, psychiatry, and neurology. It develops treatments across various modalities, including small molecules, regenerative medicine, and cell therapy. Sumitomo Pharma operates with global business platforms, with a strategic focus on Japan and the United States as its primary markets. The company's mission is to contribute to the betterment of healthcare and fuller lives for people worldwide by translating scientific innovation into real-world solutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Sumitomo Pharma Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-27 09:05
Regulatory News Service
臨時報告書
Japanese 29.6 KB
2025-06-26 09:39
Registration Form
確認書
Japanese 8.7 KB
2025-06-26 09:36
Governance Information
内部統制報告書-第205期(2024/04/01-2025/03/31)
Japanese 24.0 KB
2025-06-26 09:31
Annual Report
有価証券報告書-第205期(2024/04/01-2025/03/31)
Japanese 2.1 MB
2025-05-30 09:41
M&A Activity
訂正臨時報告書
Japanese 40.7 KB
2025-05-14 09:18
M&A Activity
訂正臨時報告書
Japanese 36.6 KB
2025-04-28 10:06
Regulatory News Service
訂正臨時報告書
Japanese 24.3 KB
2025-04-28 10:03
Regulatory News Service
臨時報告書
Japanese 19.0 KB
2025-04-03 09:39
Regulatory News Service
臨時報告書
Japanese 41.7 KB
2025-01-31 08:11
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2024-12-19 07:19
Regulatory News Service
臨時報告書
Japanese 19.2 KB
2024-11-01 03:30
Interim Report
確認書
Japanese 8.7 KB
2024-11-01 03:26
Interim Report
半期報告書-第205期(2024/04/01-2025/03/31)
Japanese 334.4 KB
2024-10-30 07:42
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-07-31 08:40
Regulatory News Service
臨時報告書
Japanese 18.7 KB

Automate Your Workflow. Get a real-time feed of all Sumitomo Pharma Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sumitomo Pharma Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SANIGEN Co., Ltd. Logo
Provides food safety solutions and genetic diagnostics for the entire food industry.
South Korea 188260
Sanofi Logo
Global biopharma firm researching, developing & marketing prescription medicines & vaccines.
France SAN
SANTEN PHARMACEUTICAL CO.,LTD. Logo
A global ophthalmology specialist developing drugs and devices for glaucoma, dry eye, and infections.
Japan 4536
Santhera Pharmaceuticals Holding AG Logo
Develops innovative medicines for rare neuromuscular and mitochondrial disorders.
Switzerland SANN
SAWAI GROUP HOLDINGS Co., Ltd. Logo
A leading Japanese generic drug maker expanding into digital health and wellness solutions.
Japan 4887
Scandion Oncology A/S Logo
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
Denmark SCOL
Develops high-purity stem cell therapies for incurable immunological and inflammatory diseases.
South Korea 298060
Seach Medical Group Ltd. Logo
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel SEMG
SEEGENE, INC. Logo
Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.
South Korea 096530
SEIKAGAKU CORPORATION Logo
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan 4548

Talk to a Data Expert

Have a question? We'll get back to you promptly.